E-ISSN 2534-9821
 

Case Report
Online Published: 26 May 2020
 


Fibroblast growth factor: A target for covid-19 infection

Pedro Cuevas, Antonio Manquillo, Pedro Guillen, Guillermo Giménez-gallego.


Cited By: 7

Abstract
In the last few months, covid-19 has spread as a highly contagious pandemic. Currently no therapies have proven to be effective for the treatment of this severe illness that progresses with a strong inflammation in different organs and systems. Because fibroblast growth factor (FGF) is a potent inflammatory agent, we have tested, in one patient who didn’t respond to the protocol therapy, the effect of FGF inhibition with an anti-inflammatory and antiviral compound with a large history of medical use which was reported as the most effective anti-FGF inhibitor: dobesilate. After five days of oral treatment, dobesilate resulted in amelioration of chest radiographies as well as in clinical improvement, opening a new possible therapeutic mean to be tested in patients.

Key words: Covid-19 infection, fibroblast growth factor, dobesilate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedro Cuevas
Articles by Antonio Manquillo
Articles by Pedro Guillen
Articles by Guillermo GIménez-Gallego
on Google
on Google Scholar


This Article Cited By the following articles

Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution
Journal of Theoretical Biology 2024; 583(): 111769.

1
 
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
Scientific Reports 2022; 12(1): .

2
 
Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches
International Journal of Molecular Sciences 2022; 23(18): 10860.

3
 
Study protocol for assessment of the efficacy of calcium dobesilate versus placebo on SARS-CoV-2 viral load in outpatients with COVID-19 (CADOVID study): a randomised, placebo-controlled, double-blind, monocentric phase II trial
BMJ Open 2024; 14(5): e079574.

4
 
FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection
Signal Transduction and Targeted Therapy 2024; 9(1): .

5
 
Protein network analysis reveals SARS-CoV-2’s potential mechanisms in accelerating lung cancer tumorigenesis using immune signaling pathways
Network Modeling Analysis in Health Informatics and Bioinformatics 2025; 14(1): .

6
 
Fibroblast Growth Factors in Lung Development and Regeneration: Mechanisms and Therapeutic Potential
Cells 2025; 14(16): 1256.

7
 
How to Cite this Article
Pubmed Style

Cuevas P, Manquillo A, Guillen P, Giménez-gallego G. Fibroblast growth factor: A target for covid-19 infection. Int J Med Rev Case Rep. 2020; 4(5): 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19


Web Style

Cuevas P, Manquillo A, Guillen P, Giménez-gallego G. Fibroblast growth factor: A target for covid-19 infection. https://www.mdpub.net//?mno=103656 [Access: June 23, 2026]. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19


AMA (American Medical Association) Style

Cuevas P, Manquillo A, Guillen P, Giménez-gallego G. Fibroblast growth factor: A target for covid-19 infection. Int J Med Rev Case Rep. 2020; 4(5): 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



Vancouver/ICMJE Style

Cuevas P, Manquillo A, Guillen P, Giménez-gallego G. Fibroblast growth factor: A target for covid-19 infection. Int J Med Rev Case Rep. (2020), [cited June 23, 2026]; 4(5): 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



Harvard Style

Cuevas, P., Manquillo, . A., Guillen, . P. & Giménez-gallego, . G. (2020) Fibroblast growth factor: A target for covid-19 infection. Int J Med Rev Case Rep, 4 (5), 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



Turabian Style

Cuevas, Pedro, Antonio Manquillo, Pedro Guillen, and Guillermo Giménez-gallego. 2020. Fibroblast growth factor: A target for covid-19 infection. International Journal of Medical Reviews and Case Reports, 4 (5), 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



Chicago Style

Cuevas, Pedro, Antonio Manquillo, Pedro Guillen, and Guillermo Giménez-gallego. "Fibroblast growth factor: A target for covid-19 infection." International Journal of Medical Reviews and Case Reports 4 (2020), 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



MLA (The Modern Language Association) Style

Cuevas, Pedro, Antonio Manquillo, Pedro Guillen, and Guillermo Giménez-gallego. "Fibroblast growth factor: A target for covid-19 infection." International Journal of Medical Reviews and Case Reports 4.5 (2020), 122-125. Print. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19



APA (American Psychological Association) Style

Cuevas, P., Manquillo, . A., Guillen, . P. & Giménez-gallego, . G. (2020) Fibroblast growth factor: A target for covid-19 infection. International Journal of Medical Reviews and Case Reports, 4 (5), 122-125. doi:10.5455/IJMRCR.Fibroblast-growth-factor-COVID-19